Trident Pharmaceuticals, Inc.
Records under this name other than patents Trident Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Trident Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,914,791 | Vaccine Lapsed on the fee record Ended Mar 29, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2019 | From the USPTO record |
| US 8,992,940 | Agent for treating allergic or hypersensitivity condition Term ended Ended no later than Jan 8, 2019 · From the USPTO record | Term ended | Ended no later than Jan 8, 2019 | From the USPTO record |
| US 6,287,563 | Therapeutic agents and autoimmune diseases Term ended Term ended Dec 29, 2017 · From the USPTO record | Term ended | Term ended Dec 29, 2017 | From the USPTO record |
| US 7,588,763 | Methods for the prevention against or treatment of diabetes with ETXB and/or insulin Formerly held Lapsed on the fee record Ended Sep 15, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2017 | From the USPTO record |
| US 8,357,372 | Agent for treating allergic or hypersensitivity condition Lapsed on the fee record Ended Jan 22, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2017 | From the USPTO record |
| US 7,208,155 | Agent for treating allergic or hypersensitivity condition Lapsed on the fee record Ended Apr 24, 2011 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2011 | From the USPTO record |